A detailed history of Tfg Asset Management Gp LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 192,000 shares of CLDX stock, worth $3.84 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares
192,000
Previous 192,000 -0.0%
Holding current value
$3.84 Million
Previous $4.85 Million -0.0%
% of portfolio
1.59%
Previous 1.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$23.31 - $32.4 $4.48 Million - $6.22 Million
192,000 New
192,000 $4.85 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $935M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Tfg Asset Management Gp LTD Portfolio

Follow Tfg Asset Management Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Asset Management Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Asset Management Gp LTD with notifications on news.